APA (7th ed.) Citation

Zhou, J., Kochan, J., Yin, O., Warren, V., Zamora, C., Atiee, G., . . . Dishy, V. (2017). A first‐in‐human study of DS‐1040, an inhibitor of the activated form of thrombin‐activatable fibrinolysis inhibitor, in healthy subjects. Journal of thrombosis and haemostasis, 15(5), 961-971. https://doi.org/10.1111/jth.13658

Chicago Style (17th ed.) Citation

Zhou, J., et al. "A First‐in‐human Study of DS‐1040, an Inhibitor of the Activated Form of Thrombin‐activatable Fibrinolysis Inhibitor, in Healthy Subjects." Journal of Thrombosis and Haemostasis 15, no. 5 (2017): 961-971. https://doi.org/10.1111/jth.13658.

MLA (9th ed.) Citation

Zhou, J., et al. "A First‐in‐human Study of DS‐1040, an Inhibitor of the Activated Form of Thrombin‐activatable Fibrinolysis Inhibitor, in Healthy Subjects." Journal of Thrombosis and Haemostasis, vol. 15, no. 5, 2017, pp. 961-971, https://doi.org/10.1111/jth.13658.